Sign in
Groups
Researchers
Results
MIGUEL JOSÉ
MARTÍN JIMÉNEZ
Catedrático de universidad
Moscow City Oncology Hospital №62
Moscú, Rusia
You are in
Collaborations
Moscow City Oncology Hospital №62
Publications in collaboration with researchers from Moscow City Oncology Hospital №62 (2)
2019
Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study
Journal of Clinical Oncology
2018
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 1, pp. 115-126
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de